HLA and bronchopulmonary dysplasia susceptibility: A pilot study

Disease Markers

Volumn 31, Issue 4, 2011, Pages 199-203

  Rocha, Gustavo ^a,e   Proença, Elisa ^b   Areias, Augusta ^b   Freitas, Fátima ^c   Lima, Bruno ^c   Rodrigues, Teresa ^d,e   Alves, Helena ^c   Guimarães, Hercília ^a,e  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Centro Hospitalar Universitario do Porto   (Portugal)

^c Centre of Histocompatibility of Porto   (Portugal)

^d Department of Hygiene and Epidemiology ^*  (Portugal)

^e University of Porto   (Portugal)

Author keywords

bronchopulmonary dysplasia; HLA; major histocompatibility complex; preterm newborn

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HUMAN; HUMAN CELL; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PILOT STUDY; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 81055147532     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0811     Document Type: Article

References (15)

1. V. Bhandari, M.J. Bizzarro, A. Shetty et al., for the Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins, Pediatrics 117 (2006), 1901-1906. (Pubitemid 46071232)
2. G. Bokodi, A. Treszl, L. Kovács et al., Dysplasia: A review, Pediatr Pulmonol 42 (2007), 952-61. (Pubitemid 47549803)
3. D.A. Clark, L.G. Pincus, M. Oliphant et al., HLA-A2 and chronic lung disease in neonates, J AmMed Assoc 248 (1982), 1868-1869. (Pubitemid 12028351)
4. U. Christen and M.G. von Herrath, Induction, acceleration or prevention of autoimmunity by molecular mimicry, Mol Immunol 40 (2004), 1113-1120. (Pubitemid 38221193)
5. U. Christen and M.G. von Herrath, Infections and autoimmunity - good or bad J Immunol 174 (2005), 7481-7486.
6. H. Christou and D. Brodsky, Lung injury and bronchopulmonary dysplasia in newborn infants, J Intensive Care Med 20 (2005), 76-87. (Pubitemid 43093899)
7. A. Jobe and E. Bancalari, NICHD/NHLBI/ORD Workshop Summary - Bronchopulmonary Dysplasia, Am J Respir Crit Care Med 163 (2001), 1723-1729.
8. J.P. Kinsella, A. Greenough and S.H. Abman, Bronchopulmonary dysplasia, Lancet 367 (2006), 1421-1431.
9. P.M. Lavoie, C. Pham and K.L. Jang, Heritability of bronchopulmonary dysplasia, defined according to the Consensus Statement of the National Institutes of Health, Pediatrics 122 (2008), 479-485.
10. H.MacDonald, American Academy of Pediatrics. Committee on Fetus and Newborn Perinatal Care at the Threshold of Viability, Pediatrics 110 (2002), 1024-1027.
11. G.T. Nepom, The major histocompatibility complex, in:Harrison's Principles of Internal Medicine, (17th ed.), A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Janeson and J. Loscalzo, eds, New York, The McGraw-Hill Companies, Inc; 2008, 2045-2053.
12. L.A. Parton, S.S. Strassberg, D. Qian et al., The genetic basis for bronchopulmonary dysplasia, Front Biosci 11 (2006), 1854-1860. (Pubitemid 43253398)
13. W.J. Pichler, Drug-induced autoimmunity, Curr Opin Allergy Clin Immunol 3 (2003), 249-253. (Pubitemid 37010879)
14. D. Rosen, J.H. Lee, F. Cuttitta et al., Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia, Am J Respir Crit Care Med 174 (2010), 75-83. (Pubitemid 43955247)
15. B. Mailaparambil, M. Krueger, U. Heizmann et al., Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia, Dis Markers 29 (2010), 1-9.